University of California, Irvine

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

172

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

8 drugs in development

Approved1

Phase 34

Phase 24

Phase 11

Preclinical3

By Therapeutic Area

top 5

Oncology

429%

Infectious Disease

214%

Neurology

17%

Psychiatry

17%

Gastroenterology

17%

R&D Momentum

79/100

Pipeline Velocity

47/100

Trial Completion Rate

68/100

Pipeline Concentration

24/100

Pipeline Freshness

64/100

Strategic Signals

↗Active in Neurology but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Sep 19, 2026

Recruiting

A Pilot Study Assessing the Safety of an Active Surveillance Approach to Local Therapy in Patients With Brain Metastases Undergoing CNS-Penetrating Systemic Therapy

Sep 18, 2026

Recruiting

Erector Spinae Plane Block for Patients With Intractable Abdominal Pain in the Emergency Department: A Pilot Study

Earlier

Sep 1, 2026TrialA Randomized Controlled, Type 1 Hybrid Effectiveness-implementation Trial Study to Compare the Effectiveness of a Patient-Reported Outcomes (PRO)-Driven Culturally Grounded Supportive Care Navigation in Reducing Healthcare Disparities Among Hispanic/Latinx Patients Receiving Anticancer Therapies

Sep 1, 2026TrialPilot Trial Comparing Circulating Tumor DNA (ctDNA) From Immediate Draining Vein vs. Standard Peripheral Vein Sample in Patients Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

Sep 1, 2026TrialPhase II Basket Trial of Intraperitoneal Paclitaxel Plus Systemic Therapy in Gastrointestinal Malignancies With Peritoneal Carcinomatosis (STOPGAP - B)

Sep 1, 2026TrialNon-invasive Skin Imaging Using Multiphoton Microscopy

Aug 27, 2026TrialRelaxation Music for Patients With Chronic Pain From IBS, Crohn's, or Colitis

Aug 27, 2026TrialHarnessing Online Peer Education For Fitness in People With Type II Diabetes

1 more events

Aug 27, 2026TrialFamily Relationship Help

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Therapeutic Area

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Gastroenterology(1 drug)

—

Gastroenterology(1 drug)

Infectious Disease(2 drugs)

—

Infectious Disease(2 drugs)

Neurology(1 drug)

—

Neurology(1 drug)

Oncology(4 drugs)

—

Oncology(4 drugs)

Psychiatry(1 drug)

—

Psychiatry(1 drug)

Unknown / Other(5 drugs)

—

Unknown / Other(5 drugs)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)